Clinical Trials Browser

Completed × NETWORK × nintedanib × Clear all

NCT01788982 2020-07-31

Nintedanib(BIBF1120) in Thyroid Cancer

Phase 2 Completed

Thyroid Neoplasms, Carcinoma, Medullary

NCT01225887 2017-10-09

Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

37 enrolled 11 charts

GenitourinaryGynecologic

Endometrial Adenocarcinoma